Identification of BCR::ABL1 as the primary genetic event is critical, as are the presence of AML-specific secondary abnormalities (especially NPM1 mutations) and the absence of ABL1 TKD point mutations. The gene discussed is ABL1; the disease is acute myeloid leukemia.